Research ArticleOriginal Article
Open Access

Prevalence of herbal medicines in patients with chronic allergic disorders in Western Saudi Arabia

Abdulrahman E. Koshak
Saudi Medical Journal April 2019, 40 (4) 391-396; DOI: https://doi.org/10.15537/smj.2019.4.24006

References

  1. ↵
    Global Atlas of Allergy, European Academy of Allergy and Clinical Immunology. URL:http://www.eaaci.org/GlobalAtlas/GlobalAtlasAllergy.pdf. [Updated 2014;Accessed 2018 June 25].
  2. ↵
    1. Moradi-Lakeh M,
    2. El Bcheraoui C,
    3. Daoud F,
    4. Tuffaha M,
    5. Kravitz H,
    6. Al Saeedi M,
    7. et al.
    (2015) Prevalence of asthma in Saudi adults:findings from a national household survey, 2013. BMC Pulm Med 15:77.
    OpenUrl
  3. ↵
    1. Sobki SH,
    2. Zakzouk SM
    (2004) Point prevalence of allergic rhinitis among Saudi children. Rhinology 42:137–140.
    OpenUrlPubMed
  4. ↵
    1. Al Ghobain MO,
    2. Al-Hajjaj MS,
    3. Al Moamary MS
    (2012) Asthma prevalence among 16- to 18-year-old adolescents in Saudi Arabia using the ISAAC questionnaire. BMC Public Health 12:239.
    OpenUrlCrossRefPubMed
  5. ↵
    1. Al-Ghobain MO,
    2. Al-Moamary MS,
    3. Al-Hajjaj MS,
    4. Al-Fayez AI,
    5. Basha SI
    (2013) Prevalence of rhinitis symptoms among 16 to 18 years old adolescents in Saudi Arabia. Indian J Chest Dis Allied Sci 55:11–14.
    OpenUrlPubMed
  6. ↵
    1. Nahhas M,
    2. Bhopal R,
    3. Anandan C,
    4. Elton R,
    5. Sheikh A
    (2012) Prevalence of allergic disorders among primary school-aged children in Madinah, Saudi Arabia:two-stage cross-sectional survey. PLoS One 7:e36848.
    OpenUrlPubMed
  7. ↵
    1. Sabry EY
    (2011) Prevalence of allergic diseases in a sample of Taif citizens assessed by an original Arabic questionnaire (phase I). Allergol Immunopathol (Madr) 39:96–105.
    OpenUrlPubMed
  8. ↵
    1. Cota BB,
    2. Bertollo CM,
    3. de Oliveira DM
    (2013) Anti-allergic potential of herbs and herbal natural products - activities and patents. Recent Pat Endocr Metab Immune Drug Discov 7:26–56.
    OpenUrl
  9. ↵
    1. Roy A,
    2. Lurslurchachai L,
    3. Halm EA,
    4. Li XM,
    5. Leventhal H,
    6. Wisnivesky JP
    (2010) Use of herbal remedies and adherence to inhaled corticosteroids among inner-city asthmatic patients. Ann Allergy Asthma Immunol 104:132–138.
    OpenUrlCrossRefPubMedWeb of Science
  10. ↵
    1. Yonekura S,
    2. Okamoto Y,
    3. Sakurai D,
    4. Sakurai T,
    5. Iinuma T,
    6. Yamamoto H,
    7. et al.
    (2017) Complementary and alternative medicine for allergic rhinitis in Japan. Allergol Int 66:425–431.
    OpenUrl
  11. ↵
    1. Gönül M,
    2. Gül U,
    3. Cakmak SK,
    4. Kiliç S
    (2009) Unconventional medicine in dermatology outpatients in Turkey. Int J Dermatol 48:639–644.
    OpenUrlCrossRefPubMed
  12. ↵
    1. Alshagga MA,
    2. Al-Dubai SA,
    3. Muhamad Faiq SS,
    4. Yusuf AA
    (2011) Use of complementary and alternative medicine among asthmatic patients in primary care clinics in Malaysia. Ann Thorac Med 6:115–119.
    OpenUrlPubMed
  13. ↵
    1. Schäfer T
    (2004) Epidemiology of complementary alternative medicine for asthma and allergy in Europe and Germany. Ann Allergy Asthma Immunol 93:S5–S10.
    OpenUrlPubMedWeb of Science
  14. ↵
    1. Johnston GA,
    2. Bilbao RM,
    3. Graham-Brown RA
    (2003) The use of complementary medicine in children with atopic dermatitis in secondary care in Leicester. Br J Dermatol 149:566–571.
    OpenUrlCrossRefPubMedWeb of Science
  15. ↵
    1. Jensen P
    (1990) Use of alternative medicine by patients with atopic dermatitis and psoriasis. Acta Derm Venereol 70:421–424.
    OpenUrlPubMedWeb of Science
    1. AlBraik FA,
    2. Rutter PM,
    3. Brown D
    (2008) A cross-sectional survey of herbal remedy taking by United Arab Emirate (UAE) citizens in Abu Dhabi. Pharmacoepidemiol Drug Saf 17:725–732.
    OpenUrlCrossRefPubMed
  17. ↵
    1. Silverberg JI,
    2. Lee-Wong M,
    3. Silverberg NB
    (2014) Complementary and alternative medicines and childhood eczema:a US population-based study. Dermatitis 25:246–254.
    OpenUrl
  18. ↵
    1. Shen J,
    2. Oraka E
    (2012) Complementary and alternative medicine (CAM) use among children with current asthma. Prev Med 54:27–31.
    OpenUrlCrossRefPubMed
  19. ↵
    1. Fuhrmann T,
    2. Smith N,
    3. Tausk F
    (2010) Use of complementary and alternative medicine among adults with skin disease:updated results from a national survey. J Am Acad Dermatol 63:1000–1005.
    OpenUrlPubMed
  20. ↵
    1. Pourhoseingholi MA,
    2. Vahedi M,
    3. Rahimzadeh M
    (2013) Sample size calculation in medical studies. Gastroenterol Hepatol Bed Bench 6:14–17.
    OpenUrlPubMed
  21. ↵
    1. Al Moamary MS
    (2008) Unconventional therapy use among asthma patients in a tertiary care center in Riyadh, Saudi Arabia. Ann Thorac Med 3:48–51.
    OpenUrlCrossRefPubMed
  22. ↵
    1. Simpson EL,
    2. Basco M,
    3. Hanifin J
    (2003) A cross-sectional survey of complementary and alternative medicine use in patients with atopic dermatitis. Am J Contact Dermat 14:144–147.
    OpenUrlPubMed
  23. ↵
    1. Hughes R,
    2. Ward D,
    3. Tobin AM,
    4. Keegan K,
    5. Kirby B
    (2007) The use of alternative medicine in pediatric patients with atopic dermatitis. Pediatr Dermatol 24:118–120.
    OpenUrlCrossRefPubMed
  24. ↵
    1. Sayin I,
    2. Cingi C,
    3. Oghan F,
    4. Baykal B,
    5. Ulusoy S
    (2013) Complementary therapies in allergic rhinitis. ISRN Allergy 2013:938751.
    OpenUrl
  25. ↵
    1. Demoly P,
    2. Annunziata K,
    3. Gubba E,
    4. Adamek L
    (2012) Repeated cross-sectional survey of patient-reported asthma control in Europe in the past 5 years. Eur Respir Rev 21:66–74.
    OpenUrlAbstract/FREE Full Text
  26. ↵
    1. Price D,
    2. Fletcher M,
    3. van der Molen T
    (2014) Asthma control and management in 8,000 European patients:the REcognise Asthma and LInk to Symptoms and Experience (REALISE) survey. NPJ Prim Care Respir Med 24:14009.
    OpenUrlCrossRefPubMed
  27. ↵
    1. Koshak A,
    2. Koshak E,
    3. Heinrich M
    (2017) Medicinal benefits of Nigella sativa in bronchial asthma:A literature review. Saudi Pharm J 25:1130–1136.
    OpenUrl
  28. ↵
    1. Yamada P,
    2. Zarrouk M,
    3. Kawasaki K,
    4. Isoda H
    (2008) Inhibitory effect of various Tunisian olive oils on chemical mediator release and cytokine production by basophilic cells. J Ethnopharmacol 116:279–287.
    OpenUrlPubMed
    1. Chandak R,
    2. Devdhe S,
    3. Changediya V
    (2009) Evaluation of anti-histaminic activity ofaqueous extract of ripe olives of olea-europea. J Pharm Res 2:416–420.
    OpenUrl
    1. Fezai M,
    2. Senovilla L,
    3. Jemaà M,
    4. Ben-Attia M
    (2013) Analgesic, anti-inflammatory and anticancer activities of extra virgin olive oil. J Lipids 2013:129736.
    OpenUrl
  31. ↵
    1. Cicerale S,
    2. Lucas LJ,
    3. Keast RS
    (2012) Antimicrobial, antioxidant and anti-inflammatory phenolic activities in extra virgin olive oil. Curr Opin Biotechnol 23:129–135.
    OpenUrlCrossRefPubMedWeb of Science
  32. ↵
    1. Barbalho SM,
    2. Farinazzi-Machado FMV,
    3. Goulart de Alvares R,
    4. Brunnati ACS,
    5. Ottoboni AMB,
    6. Nicolau CT
    (2012) Psidium Guajava (Guava):A Plant of Multipurpose Medicinal Applications. Med Aromat Plants 1:104.
    OpenUrl
  33. ↵
    1. Kawamoto Y,
    2. Ueno Y,
    3. Nakahashi E,
    4. Obayashi M,
    5. Sugihara K,
    6. Qiao S,
    7. et al.
    (2016) Prevention of allergic rhinitis by ginger and the molecular basis of immunosuppression by 6-gingerol through T cell inactivation. J Nutr Biochem 27:112–122.
    OpenUrl
    1. Malhotra S,
    2. Singh AP
    (2003) Medicinal properties of ginger (Zingiber officinale Rosc.). Nat Prod Radiance 2:296–301.
    OpenUrl
  35. ↵
    1. Chen BH,
    2. Wu PY,
    3. Chen KM,
    4. Fu TF,
    5. Wang HM,
    6. Chen CY
    (2009) Antiallergic potential on RBL-2H3 cells of some phenolic constituents of Zingiber officinale (ginger). J Nat Prod 72:950–953.
    OpenUrlPubMed
  36. ↵
    1. Shin HS,
    2. See HJ,
    3. Jung SY,
    4. Choi DW,
    5. Kwon DA,
    6. Bae MJ,
    7. et al.
    (2015) Turmeric (Curcuma longa) attenuates food allergy symptoms by regulating type 1/type 2 helper T cells (Th1/Th2) balance in a mouse model of food allergy. J Ethnopharmacol 175:21–29.
    OpenUrl
    1. Kocaadam B,
    2. Şanlier N
    (2017) Curcumin, an active component of turmeric (Curcuma longa), and its effects on health. Crit Rev Food Sci Nutr 57:2889–2895.
    OpenUrlPubMed
    1. Owaga EE,
    2. Mpondab J,
    3. Nyang'injac J
    (2014) Nutrigenomic approach in understanding the antiallergic effects of curcumin. Asian J Biomed Pharm Sci 4:1–5.
    OpenUrl
  39. ↵
    1. Suzuki M,
    2. Nakamura T,
    3. Iyoki S,
    4. Fujiwara A,
    5. Watanabe Y,
    6. Mohri K,
    7. et al.
    (2005) Elucidation of anti-allergic activities of curcumin-related compounds with a special reference to their anti-oxidative activities. Biol Pharm Bull 28:1438–1443.
    OpenUrlPubMed
  40. ↵
    1. Iram F,
    2. Khan SA,
    3. Husain A
    (2017) Phytochemistry and potential therapeutic actions of Boswellic acids:A mini-review. Asian Pac J Trop Biomed 7:513–523.
    OpenUrl
  41. ↵
    1. Sharma ML,
    2. Kaul A,
    3. Khajuria A,
    4. Singh S,
    5. Singh GB
    (1996) Immunomodulatory Activity of Boswellic Acids (Pentacyclic Triterpene Acids) from Boswellia serrata. Phyther Res 10:107–112.
    OpenUrl
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools
Bookmark this article

Jump to section